After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The r ...

People who develop MS at a younger age tend to have better long-term physical health but worse mental health than those ...

NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced encouraging results from its PoNSTEP study, presented at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual ...

PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of ...

Detailed price information for Helius Medical Technologies Inc (HSDT-Q) from The Globe and Mail including charting and trades.

In Europe, theoretical approaches to physical therapy and rehabilitation in multiple sclerosis often appear significantly different. While there is general agreement that rehabilitation plays an ...

Physical therapy can significantly improve mobility, reduce fatigue, and enhance quality of life for people with MS, whether they are newly diagnosed or have been living with the condition for years.

Helius Medical Technologies, Inc. announced that it will present results from its new study on the Portable Neuromodulation Stimulator (PoNS®) at the upcoming Consortium of Multiple Sclerosis ...

WEST PALM BEACH, Fla. — For patients with MS, the risk for disability worsening was reduced with physical activity, highlighting the importance of recommending it in practice, researchers ...

--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis ...